Skip to content
buyWeak cluster of 410b5-1 plan

Caroline Young bought $417 of CPIX

director at CUMBERLAND PHARMACEUTICALS INC. 93 shares at an average of $4.48, traded Apr 1, 2025, filed May 9, 2025.

Conviction score
23
Value
$417
93 shares
Holdings after
32,485
+0% from before
From 52-week low
+311%
low $0.82, close $3.38
From 52-week high
-36%
high $5.25, as of Apr 1, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $417 at market
    0
  • Relative to holdings
    Under 1% of holdings (0.3%)
    -5
  • Price context
    36% below the 52-week high
    +8
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    2 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (1 with prices)
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -15

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CPIXOct 9, 2026 · close 7.03
Since filing May 9, 2025: +92.9%SPY +40.2% · excess +52.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-024355, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 1, 2025POpen-market purchase
Common Stock10b5-1
+4$4.24$1732,396May 9, 2025
Apr 2, 2025POpen-market purchase
Common Stock10b5-1
+4$4.39$1832,400May 9, 2025
Apr 3, 2025POpen-market purchase
Common Stock10b5-1
+4$4.21$1732,404May 9, 2025
Apr 4, 2025POpen-market purchase
Common Stock10b5-1
+4$4.23$1732,408May 9, 2025
Apr 7, 2025POpen-market purchase
Common Stock10b5-1
+4$4.19$1732,412May 9, 2025
Apr 8, 2025POpen-market purchase
Common Stock10b5-1
+4$4.14$1732,416May 9, 2025
Apr 9, 2025POpen-market purchase
Common Stock10b5-1
+4$4.09$1632,420May 9, 2025
Apr 10, 2025POpen-market purchase
Common Stock10b5-1
+4$4.01$1632,424May 9, 2025
Apr 11, 2025POpen-market purchase
Common Stock10b5-1
+4$4.02$1632,428May 9, 2025
Apr 14, 2025POpen-market purchase
Common Stock10b5-1
+5$4.03$2032,433May 9, 2025
Apr 15, 2025POpen-market purchase
Common Stock10b5-1
+5$4.14$2132,438May 9, 2025
Apr 16, 2025POpen-market purchase
Common Stock10b5-1
+5$4.23$2132,443May 9, 2025
Apr 17, 2025POpen-market purchase
Common Stock10b5-1
+5$4.61$2332,448May 9, 2025
Apr 21, 2025POpen-market purchase
Common Stock10b5-1
+5$4.79$2432,453May 9, 2025
Apr 22, 2025POpen-market purchase
Common Stock10b5-1
+5$4.74$2432,458May 9, 2025
Apr 23, 2025POpen-market purchase
Common Stock10b5-1
+5$5.01$2532,463May 9, 2025
Apr 24, 2025POpen-market purchase
Common Stock10b5-1
+5$5.12$2632,468May 9, 2025
Apr 25, 2025POpen-market purchase
Common Stock10b5-1
+5$4.94$2532,473May 9, 2025
Apr 28, 2025POpen-market purchase
Common Stock10b5-1
+4$4.91$2032,477May 9, 2025
Apr 29, 2025POpen-market purchase
Common Stock10b5-1
+4$4.93$2032,481May 9, 2025
Apr 30, 2025POpen-market purchase
Common Stock10b5-1
+4$4.79$1932,485May 9, 2025

Related signals

Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
29Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$858
168 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$429
84 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$858
168 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,824
945 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,635
1,035 shares
+0%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$833
186 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$833
186 shares
+0%
14Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,548
875 shares
+0%
24Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$881
168 shares
+0%
14Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$881
168 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Caroline Young bought $417 of CPIX | InsiderTell